subject: Biopharmaceuticals Market is Projected to Grow by a CAGR (2006-2015) of 12.4% to touch $182.5bn [print this page] Intense research efforts made biopharmaceuticals the most successful products in various therapeutic areas such as Neurology, Infectious Diseases, Cardiovascular, Oncology etc. Undoubtedly, all the major pharmaceuticals are, now, engaged in doing research for new biopharmaceutical active ingredients. Biopharma active ingredients are containing in about 50% of the newly approved drugs. The future of biopharmaceuticals is to be projected bright as the market share is growing gradually. In terms of market revenue, out of total pharma market the biopharmaceutical products were accounted for about 10% in 2006 and are projected to account for about 15% by 2015.
Biopharmaceutical products analyzed in this study comprise Monoclonal Antibodies, Biotech Vaccines, Erythropoietin, Granulocyte-Colony Stimulating Factor, Recombinant Human Insulin, Interferons, Human Growth Hormones and Other. The report also analyzes the market for biopharmaceutical therapeutic areas including Oncology, Neurology, Diabetes, Infectious Diseases, Cardiovascular and Other.
The global market for biopharmaceuticals is projected to reach US$182.5 billion by 2015, registering a CAGR of 12.4% during the period 2006-2015. The study includes 131 charts (includes a data table and graphical representation for each chart), supported with meaningful and easy to understand graphical presentation, of market numbers. The statistical tables represent the data for the global market value in USD by geographic regions and the product segments.
The report analyses the biopharmaceuticals market for global and the regional markets including North America, Western Europe, Asia-Pacific and Rest of World. The regional markets further analyzed for 10 independent countries across North America the United States and Canada; Europe Germany, The United Kingdom, France, Italy and Spain; Asia-Pacific Japan, China and India.
This study profiles 53 key global players and 87 major players across North America 37; Western Europe 18; Asia-Pacific 30; and Rest of World 2. The report also provides the listing of the companies engaged in research, technology development, manufacturing and the supply of biopharmaceuticals. The global list of companies covers addresses, contact numbers and the website addresses of 382 companies.
Table of Contents
1. GLOBAL MARKET PERSPECTIVE
1.1 Introduction
1.2 Product Segmentation
1.3 Application Analysis
1.4 Market Trends
1.5 Key Global Players
1.6 Key Business Trends
1.7 Key Product Trends
1.8 Global Market Overview
2. REGIONAL MARKET PERSPECTIVE
2.1 Regional Market Overview
2.1.1 North America
2.1.1.2 Market Overview by North American Region
2.1.1.3 Market Overview by Biopharmaceutical Product
2.1.1.4 Market Overview by Biopharmaceutical Therapeutic Area
2.1.1.5 Biopharmaceutical Product Market Overview by North American Region
2.1.1.6 Major Market Players
2.1.1.7 North American Market Overview by Country
2.1.2 Western Europe
2.1.2.1 Market Overview by Western Europe Region
2.1.2.3 Market Overview by Biopharmaceutical Product
2.1.2.3 Market Overview by Biopharmaceutical Therapeutic Area
2.1.2.4 Biopharmaceutical Product Market Overview by Western Europe Region
2.1.2.6 Western Europe Market Overview by Country
2.1.3 Asia-Pacific
2.1.3.1 Market Overview by Asia-Pacific Region
2.1.3.2 Market Overview by Biopharmaceutical Product
2.1.3.3 Market Overview by Biopharmaceutical Therapeutic Area
2.1.3.4 Biopharmaceutical Product Market Overview by Asia-Pacific Region
2.1.3.5 Major Market Players
2.1.3.6 Asia-Pacific Market Overview by Country
2.1.4 Rest of World
2.1.4.1 Market Overview by Biopharmaceutical Product
2.1.4.2 Market Overview by Biopharmaceutical Therapeutic Area
